Literature DB >> 6463212

Arrest of irradiated G1, S, or G2 cells at mitosis using nocodazole promotes repair of potentially lethal damage.

G Iliakis, M Nüsse.   

Abstract

The ability of synchronized Ehrlich ascites tumor cells, irradiated in G1, S, and G2 phases, to repair potentially lethal damage when arrested at mitosis by using 0.4 microgram/ml nocodazole, a specific inhibitor of microtubule polymerization, has been studied. Cells irradiated in these phases were found to repair potentially lethal damage at mitosis. The extent of this repair was similar to that observed for cells irradiated at the same stages in the cell cycle but allowed to repair potentially lethal damage by incubating in balanced salt solution for 6 hr after X irradiation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6463212

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  5 in total

1.  The importance of G1/S-border and mitosis in the fixation of potentially lethal damage.

Authors:  G Iliakis; M Nüsse
Journal:  Radiat Environ Biophys       Date:  1983       Impact factor: 1.925

2.  Single agents with designed combination chemotherapy potential: synthesis and evaluation of substituted pyrimido[4,5-b]indoles as receptor tyrosine kinase and thymidylate synthase inhibitors and as antitumor agents.

Authors:  Aleem Gangjee; Nilesh Zaware; Sudhir Raghavan; Michael Ihnat; Satyendra Shenoy; Roy L Kisliuk
Journal:  J Med Chem       Date:  2010-02-25       Impact factor: 7.446

3.  Effects of adenosine deaminase inhibitor 2'-deoxycoformycin on the repair and expression of potentially lethal damage sensitive to beta-araA.

Authors:  G Iliakis; F Q Ngo
Journal:  Radiat Environ Biophys       Date:  1985       Impact factor: 1.925

Review 4.  Mitogen-activated protein kinases and their role in radiation response.

Authors:  Anupama Munshi; Rajagopal Ramesh
Journal:  Genes Cancer       Date:  2013-09

5.  In vitro and in vivo radiosensitization with AZD6244 (ARRY-142886), an inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 kinase.

Authors:  Eun Joo Chung; Aaron P Brown; Hiroaki Asano; Mariana Mandler; William E Burgan; Donna Carter; Kevin Camphausen; Deborah Citrin
Journal:  Clin Cancer Res       Date:  2009-04-14       Impact factor: 12.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.